Who Paid My Doc
Eli Gordin
Facial Plastic Surgery Dallas, TX Medical Doctor
NPI 1497915540 CMS profile 22874
5323 Harry Hines Blvd, Dallas, TX 75390
General payments
$52,189
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Eli Gordin of Dallas, TX is reported in the CMS Open Payments database as having received $52,189 across 87 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 96th percentile of Facial Plastic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
7 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $121 | 4 | |
| 2024 | General | $27,889 | 30 | |
| 2023 | General | $11,624 | 23 | |
| 2022 | General | $6,370 | 12 | |
| 2021 | General | $618 | 8 | |
| 2020 | General | $4,250 | 3 | |
| 2019 | General | $1,317 | 7 |
Beside peers
- Eli Gordin
- Facial Plastic Surgery median
- Middle half of Facial Plastic Surgery
- National median
In program year 2025, general payments to Eli Gordin were reported at $121. Among 437 Facial Plastic Surgery profiles paid that year, the median was $270 and the middle half received between $116 and $579.
Show as a table
| Year | Eli Gordin | Facial Plastic Surgery median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $1,317 | $225 | $92–$651 | $163 |
| 2020 | $4,250 | $132 | $45–$323 | $114 |
| 2021 | $618 | $186 | $67–$558 | $132 |
| 2022 | $6,370 | $218 | $83–$594 | $149 |
| 2023 | $11,624 | $237 | $94–$564 | $160 |
| 2024 | $27,889 | $233 | $104–$575 | $164 |
| 2025 | $121 | $270 | $116–$579 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Billing to Medicare
Part B · data year 2024 · 54 billing codesPaid by Medicare
$58,454
Medicare patients
67
Services billed
217
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Arthritis | 43% | |
| Ischemic heart disease | 40% | |
| Diabetes | 37% | |
| COPD | 27% | |
| Depression | 27% | |
| Chronic kidney disease | 25% | |
| Heart failure | 22% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
87 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Facial Plastic Surgery in Texas
Jose Barrera
Facial Plastic Surgery · San Antonio, TX
Ifeolumipo Sofola
Facial Plastic Surgery · The Woodlands, TX
Vu Ho
Facial Plastic Surgery · Plano, TX
Edward Buckingham
Facial Plastic Surgery · Austin, TX
Tang Ho
Facial Plastic Surgery · Houston, TX
Kent Davis
Facial Plastic Surgery · Houston, TX
Related records
Facial Plastic Surgery in Texas
Practitioners in the same specialty and state, ranked by reported value.
All Facial Plastic Surgery
Everyone recorded under this specialty, nationwide.
Doctors in Texas
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.